Portola Pharmaceuticals Inc PTLA:NASDAQ

Last Price$25.89NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/17/19

Today's Change+0.21(0.82%)
Bid (Size)$16.39 (10)
Ask (Size)$28.31 (1)
Day Low / High$25.26 - 26.14
Volume684.7 K

View Pharmaceuticals: Other IndustryPeer Comparison as of 07/17/2019


Portola Pharmaceuticals Inc ( NASDAQ )

Price: $25.89
Change: +0.21 (0.82%)
Volume: 684.7 K
4:00PM ET 7/17/2019

Pacira Biosciences Inc ( NASDAQ )

Price: $40.48
Change: -0.43 (1.05%)
Volume: 360.8 K
4:00PM ET 7/17/2019

Supernus Pharmaceuticals Inc ( NASDAQ )

Price: $31.89
Change: -0.06 (0.19%)
Volume: 316.7 K
4:00PM ET 7/17/2019

Ironwood Pharmaceuticals Inc ( NASDAQ )

Price: $10.60
Change: +0.16 (1.53%)
Volume: 907.4 K
4:00PM ET 7/17/2019

Prestige Consumer Healthcare Inc ( NYSE )

Price: $31.17
Change: +0.27 (0.87%)
Volume: 501.6 K
4:02PM ET 7/17/2019

Read more news Recent News

Portola Pharmaceuticals Presents Data Demonstrating 4F-PCC Had No Direct Effect on Thrombin Inhibition
2:55PM ET 7/08/2019 MT Newswires

Portola Pharmaceuticals (PTLA) presented in vitro data showing four-factor prothrombin complex concentrates (4F-PCC) had no direct impact on the inhibition...

Portola Pharma's New Interim Data on Cerdulatinib for Relapsed Follicular Lymphoma Shows Encouraging Results
1:48PM ET 6/19/2019 MT Newswires

Portola Pharmaceuticals (PTLA) said on Wednesday new interim results from its ongoing phase 2a study of cerdulatinib in patients with relapsed follicular...

Sector Update: Health Care Stocks Underpin Wednesday's Market Recovery
3:53PM ET 5/08/2019 MT Newswires

Top Health Care Stocks JNJ +0.27% PFE +0.32% ABT -0.49% MRK +0.73% AMGN -0.66% Health care stocks rose Wednesday, including a 0.6% gain for the NYSE...

Portola Pharmaceuticals Shares Shed 12% Amid Broadly Better Performance vs Expectations
1:43PM ET 5/08/2019 MT Newswires

Portola Pharmaceuticals (PTLA) shares shed 12% in early afternoon session on Wednesday, even after the drugmaker reported a broadly better-than-expected Q1...

Company Profile

Business DescriptionPortola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. It offers Andexxa, and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. View company web site for more details
Address270 East Grand Avenue
South San Francisco, California 94080
Number of Employees324
Recent SEC Filing06/17/20194
President, Chief Executive Officer & DirectorJ. Scott Garland
CFO, Chief Business Officer & Executive VPMardi C. Dier
Senior Vice President-ResearchPamela B. Conley
Chief Technical Operations Officer & Executive VPGlenn Brame

Company Highlights

Price Open$25.66
Previous Close$25.89
52 Week Range$14.81 - 42.17
Market Capitalization$1.8 B
Shares Outstanding68.1 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement08/08/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$5.19
Beta vs. S&P 500N/A
Revenue$40.1 M
Net Profit Margin-618.45%
Return on Equity-265.32%

Analyst Ratings as of 07/05/2019

Consensus RecommendationConsensus Icon
Powered by Factset